Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mouna Akacha

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Statistics in Medicine|June 17, 2010
The impact of dropouts on the analysis of dose-finding studies with recurrent event dataMouna Akacha, Norbert Benda
Clinical Pharmacology and Therapeutics|November 10, 2017
Estimands: A More Strategic Approach to Study Design and AnalysisMouna Akacha, Wolfgang Kothny
Statistics in Medicine|February 2, 2011
Modelling the rate of change in a longitudinal study with missing data, adjusting for contact attemptsMouna Akacha, Jane L Hutton
Clinical Pharmacology and Therapeutics|September 12, 2017
Considerations for Evaluating Treatment Effects From Randomized Clinical TrialsStephen J Ruberg, Mouna Akacha
Pharmaceutical Statistics|November 6, 2015
Sensitivity analyses for partially observed recurrent event dataMouna Akacha, Emmanuel O Ogundimu
Pharmaceutical Statistics|September 5, 2015
Choice of estimand and analysis methods in diabetes trials with rescue medicationBjörn Holzhauer, Mouna Akacha, Georgina Bermann
Statistics in Medicine|July 21, 2016
Estimands in clinical trials - broadening the perspectiveMouna Akacha, Frank Bretz, Stephen Ruberg
Statistics in Medicine|November 17, 2022
Estimands in heath technology assessment: a causal inference perspectiveKelly Van Lancker, Tat-Thang Vo, Mouna Akacha
Biometrika|January 28, 2014
Estimating time-varying effects for overdispersed recurrent events data with treatment switchingQingxia Chen, Donglin Zeng, Joseph G Ibrahim, et al.
Pharmaceutical Statistics|January 11, 2020
What matters most? Different stakeholder perspectives on estimands for an invented case study in COPDOliver N Keene, Stephen Ruberg, Alexander Schacht, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Statistics in Medicine|June 17, 2010
The impact of dropouts on the analysis of dose-finding studies with recurrent event dataMouna Akacha, Norbert Benda
Clinical Pharmacology and Therapeutics|November 10, 2017
Estimands: A More Strategic Approach to Study Design and AnalysisMouna Akacha, Wolfgang Kothny
Statistics in Medicine|February 2, 2011
Modelling the rate of change in a longitudinal study with missing data, adjusting for contact attemptsMouna Akacha, Jane L Hutton
Clinical Pharmacology and Therapeutics|September 12, 2017
Considerations for Evaluating Treatment Effects From Randomized Clinical TrialsStephen J Ruberg, Mouna Akacha
Pharmaceutical Statistics|November 6, 2015
Sensitivity analyses for partially observed recurrent event dataMouna Akacha, Emmanuel O Ogundimu
Pharmaceutical Statistics|September 5, 2015
Choice of estimand and analysis methods in diabetes trials with rescue medicationBjörn Holzhauer, Mouna Akacha, Georgina Bermann
Statistics in Medicine|July 21, 2016
Estimands in clinical trials - broadening the perspectiveMouna Akacha, Frank Bretz, Stephen Ruberg
Statistics in Medicine|November 17, 2022
Estimands in heath technology assessment: a causal inference perspectiveKelly Van Lancker, Tat-Thang Vo, Mouna Akacha
Biometrika|January 28, 2014
Estimating time-varying effects for overdispersed recurrent events data with treatment switchingQingxia Chen, Donglin Zeng, Joseph G Ibrahim, et al.
Pharmaceutical Statistics|January 11, 2020
What matters most? Different stakeholder perspectives on estimands for an invented case study in COPDOliver N Keene, Stephen Ruberg, Alexander Schacht, et al.
Pageof 2